IDEU Symposium 4–5 March 2026
Wednesday, 04 March 2026 to Thursday, 05 March 2026
Richard Doll Building - Lecture Theatre
Hosted by Angela Brueggemann
Join us for the IDEU Symposium 2026, a dynamic two-day event showcasing world-leading research in infectious disease epidemiology and global health. Taking place at the Richard Doll Lecture Theatre, the symposium will bring together internationally renowned speakers, early- and mid-career researchers, and partners from across academia, healthcare, and industry.
The programme features cutting-edge talks on antimicrobial resistance, HIV, vaccines, bioengineering, mathematical modelling, and global health ethics, alongside panel discussions, poster sessions, and dedicated sessions highlighting emerging research talent within IDEU. With ample opportunities for networking and collaboration, the IDEU Symposium offers a vibrant forum to exchange ideas, spark new partnerships, and shape the future of infectious disease research.
Registration closes on Tuesday 24th February.
View the programme [PDF].
Meeting programme:
WEDNESDAY 4 MARCH
| Time | Speaker and title |
| 9:30-10:00 | Registration and coffee |
| Session 1 | Chair: Angela Brueggemann |
| 10:00-10:15 |
Welcome and introduction to the IDEU: |
| 10:15-10:35 |
Odile Harrison: Neisseria meningitidis carriage, antimicrobial resistance and risk factors in UK men who have sex with men |
| 10:35-10:55 | Danny Wilson: Linking UK Biobank to UKHSA data to find infection causes |
| 10:55-11:15 | Leon Peto: The RECOVERY platform trial: present and future |
| 11:15-11:45 | Tea, coffee, networking |
| Session 2 | Chair: Helen Fryer |
| 11:45-12:05 |
Melissa Iacovidou and Dr Phyllis Munyiva, on behalf of Professor Goylette Chami: SchistoTrack: A prospective, community-based cohort focused on intestinal schistosomiasis in Uganda |
| 12:05-12:25 | Joris Hemelaar: The unfinished business of the HIV pandemic |
| 12:25-12:45 |
Molly Stevens: Developing and translating bioengineering technologies for better health |
| 12:45-14:00 | Lunch, networking |
| Session 3 | Chair: Ana Unitt and Matt Quinn |
| 14:00-15:00 |
IDEU early- and mid-career researcher 5-minute talks Shing Zhan: Towards scalable inference of ancestral recombination graphs for bacteria Iman Yassine: Longitudinal population dynamics of Moraxella catarrhalis in the nasopharynx during the first year of life Saskia Proud: Exploring phage diversity in Haemophilus influenzae Hugh White: Evidence of human-pathogen genetic interactions in Staphylococcus aureus bloodstream infections Helen Fryer: Big data methods for identifying non-genetic risk factors for microbial disease Vanessa Tobert: The role of antibody and antigen status as biomarkers for the use of neutralising antibody therapies: analysis of 21,446 participants in the RECOVERY trial Alyssa Fitzpatrick: Adverse maternal outcomes in women living with HIV: a systematic review and meta-analysis Ayisha Khalid: Global and regional molecular epidemiology of HIV-1 during 1990-2024
Q & A (10 minutes) |
| 15:00-15:30 | Tea, coffee, networking |
| Session 4 | Chair: Prabhat Jha |
| 15:30-15:50 |
Robin Thompson: Mathematical modelling at the end of an infectious disease outbreak |
| 15:50-16:10 | Nicole Stoesser: The link’s the sink! Sinks and Gram-negative pathogens in healthcare settings |
| 16:10-16:30 | Simon Draper: Advances in vaccines and antibodies for blood-stage malaria |
| 16:30-16:50 | Caeser Atuire: Health research partnerships in a fragmenting world order |
| 17:00-19:00 |
Drinks reception in the Richard Doll Building |
THURSDAY 5 MARCH
| Time | Title |
| 9:30-10:00 | Registration and coffee |
| Session 5 | Chair: Helen Fryer |
| 10:00-10:20 |
Adrian Smith: Responding to HIV epidemics among sexual and gender minorities: live |
| 10:20-10:40 |
Angela Brueggemann: The IRIS Consortium reveals significant changes in invasive |
| 10:40-11:00 |
Mike Parker: The Global Health Bioethics Network: a collaborative network designed |
| 11:00-11:30 | Tea, coffee, networking |
| Session 6 | Chairs: Iman Yassine and Melissa Iacovidou |
| 11:30-12:35 |
IDEU early- and mid-career researcher five-minute talks plus Q&A Ana Unitt: A core genome approach to exploring antimicrobial resistance in Neisseria gonorrhoeae Krisna Made: Predicting azithromycin resistance in Neisseria gonorrhoeae using machine learning Matt Quinn: Assessing the impact of the UK RSV vaccination programme on antibiotic usage and antimicrobial resistance Priya Lall: Assessment of the feasibility of a One Health surveillance system Sandrena Frischer : Referrals in the absence of clinical management guidance: navigating continuity of care for participants in a longitudinal study on chronic schistosomiasis infection in rural Uganda Max Lang: Malaria-Schistosoma mansoni co-infection in Ugandan fishing communities Eloise Ockenden: Clinical decision support systems for periportal fibrosis staging Zizheng Zhang: Last observations of inpatient physiology data are more effective than time series in mortality prediction Kieran Johnstone: Harm from bloodstream infections in acute and emergency care Q & A (10 minutes) |
| 12:35 - 13:35 | Lunch, networking, posters |
| Session 7 | Chair: Adrian Smith and Leon Peto |
| 13:35-13:55 | Gil McVean: The Pathogen Project at EIT |
| 13:55-14:15 |
Susanne Hodgson: Human challenge studies to accelerate gonorrhoea vaccine |
| 14:15-15:15 |
Panel discussion: Open data in the age of digital epidemiology: benefits, risks, and responsibilities. Should open data be the default in infectious disease research? The panel members and audience will discuss the opportunities and challenges associated with open data Panel: Gil McVean, Ben Lacey, Odile Harrison, Joris Hemelaar, Angeliki Kerasidou |
| Session 8 | Chair: Angela Brueggemann |
| 15:20-15:40 | Industry sponsor |
| 15:40-16:00 | Industry sponsor |
| 16:00-16:15 | Closing remarks: Angela Brueggemann |
Sponsors:

